Lannett Co Inc Current Ratio 2006-2020 | LCI

Lannett Co Inc current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Lannett Co Inc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.44B $0.22B 2.02
2020-06-30 $0.44B $0.22B 2.06
2020-03-31 $0.44B $0.23B 1.97
2019-12-31 $0.45B $0.23B 1.96
2019-09-30 $0.44B $0.18B 2.43
2019-06-30 $0.47B $0.18B 2.67
2019-03-31 $0.52B $0.18B 2.88
2018-12-31 $0.60B $0.24B 2.44
2018-09-30 $0.52B $0.18B 2.87
2018-06-30 $0.53B $0.20B 2.62
2018-03-31 $0.52B $0.20B 2.56
2017-12-31 $0.57B $0.25B 2.32
2017-09-30 $0.51B $0.20B 2.52
2017-06-30 $0.50B $0.19B 2.57
2017-03-31 $0.56B $0.21B 2.63
2016-12-31 $0.67B $0.33B 2.00
2016-09-30 $0.65B $0.31B 2.07
2016-06-30 $0.61B $0.31B 2.00
2016-03-31 $0.60B $0.18B 3.40
2015-12-31 $0.61B $0.15B 4.13
2015-09-30 $0.40B $0.04B 9.94
2015-06-30 $0.37B $0.04B 8.51
2015-03-31 $0.37B $0.04B 10.52
2014-12-31 $0.33B $0.04B 7.74
2014-09-30 $0.29B $0.04B 7.12
2014-06-30 $0.27B $0.05B 5.65
2014-03-31 $0.24B $0.04B 6.37
2013-12-31 $0.20B $0.03B 5.93
2013-09-30 $0.12B $0.02B 5.04
2013-06-30 $0.12B $0.03B 3.51
2013-03-31 $0.12B $0.04B 2.95
2012-12-31 $0.12B $0.04B 2.65
2012-09-30 $0.11B $0.04B 2.88
2012-06-30 $0.09B $0.03B 3.67
2012-03-31 $0.10B $0.04B 2.84
2011-12-31 $0.10B $0.03B 2.83
2011-09-30 $0.10B $0.04B 2.76
2011-06-30 $0.09B $0.04B 2.70
2011-03-31 $0.09B $0.03B 2.71
2010-12-31 $0.09B $0.03B 2.86
2010-09-30 $0.08B $0.04B 2.00
2010-06-30 $0.09B $0.05B 1.84
2010-03-31 $0.08B $0.05B 1.85
2009-12-31 $0.07B $0.03B 2.20
2009-09-30 $0.08B $0.04B 2.21
2009-06-30 $0.08B $0.04B 2.00
2009-03-31 $0.07B $0.03B 2.08
2008-12-31 $0.06B $0.03B 2.09
2008-09-30 $0.06B $0.03B 1.87
2008-06-30 $0.06B $0.04B 1.73
2008-03-31 $0.04B $0.02B 2.12
2007-12-31 $0.04B $0.02B 2.36
2007-09-30 $0.04B $0.02B 2.17
2007-06-30 $0.04B $0.02B 1.99
2007-03-31 $0.05B $0.03B 1.88
2006-12-31 $0.04B $0.02B 2.39
2006-09-30 $0.05B $0.02B 2.17
2006-06-30 $0.04B $0.02B 2.17
2006-03-31 $0.04B $0.02B 2.03
2005-12-31 $0.04B $0.02B 2.39
2005-09-30 $0.04B $0.02B 2.04
2005-06-30 $0.03B $0.02B 2.07
2005-03-31 $0.04B $0.02B 2.57
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.281B $0.546B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.264B 42.12
Takeda Pharmaceutical (TAK) Japan $54.984B 10.26
Astellas Pharma (ALPMY) Japan $29.696B 18.55
Merck (MKGAF) Germany $23.264B 0.00
Eisai (ESALY) Japan $21.993B 19.16
UCB SA (UCBJF) Belgium $20.900B 0.00
Catalent (CTLT) United States $19.736B 59.03
Grifols, S.A (GRFS) Spain $13.600B 15.57
Neurocrine Biosciences (NBIX) United States $10.163B 79.99
Jazz Pharmaceuticals (JAZZ) Ireland $9.304B 15.03
Ionis Pharmaceuticals (IONS) United States $8.533B 83.60
Arrowhead Pharmaceuticals (ARWR) United States $8.441B 0.00
United Therapeutics (UTHR) United States $7.626B 16.24
IPSEN SA ADR (IPSEY) France $7.218B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.684B 385.28
Sage Therapeutics (SAGE) United States $4.661B 0.00
PTC Therapeutics (PTCT) United States $4.478B 0.00
ChemoCentryx (CCXI) United States $4.213B 0.00
Hypermarcas (HYPMY) Brazil $4.212B 16.63
FibroGen (FGEN) United States $4.006B 0.00
Cronos Group (CRON) Canada $3.946B 0.00
Corcept Therapeutics (CORT) United States $3.340B 32.30
Pacira BioSciences (PCRX) United States $3.208B 69.67
Nektar Therapeutics (NKTR) United States $3.089B 0.00
Revolution Medicines (RVMD) United States $2.852B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.851B 14.56
Xencor (XNCR) United States $2.842B 0.00
Tilray (TLRY) Canada $2.683B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.758B 15.04
USANA Health Sciences (USNA) United States $1.733B 15.25
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.725B 0.00
Translate Bio (TBIO) United States $1.708B 0.00
Heron Therapeutics (HRTX) United States $1.631B 0.00
Endo (ENDP) Ireland $1.626B 2.47
BioCryst Pharmaceuticals (BCRX) United States $1.601B 0.00
ImmunoGen (IMGN) United States $1.546B 0.00
Ocular Therapeutix (OCUL) United States $1.523B 0.00
Trillium Therapeutics (TRIL) Canada $1.494B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 10.06
Indivior (INVVY) United States $1.309B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.182B 0.00
Karyopharm Therapeutics (KPTI) United States $1.110B 0.00
ORGANOGENESIS (ORGO) United States $1.023B 0.00
Zogenix (ZGNX) United States $1.017B 0.00
Radius Health (RDUS) United States $1.008B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.963B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.832B 49.10
Aclaris Therapeutics (ACRS) United States $0.808B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.770B 0.00
VAXART, INC (VXRT) United States $0.756B 0.00
Aerie Pharmaceuticals (AERI) United States $0.706B 0.00
Esperion Therapeutics (ESPR) United States $0.700B 0.00
Acutus Medical (AFIB) United States $0.658B 0.00
Chinook Therapeutics (KDNY) United States $0.640B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.637B 0.00
Ardelyx (ARDX) United States $0.616B 0.00
Harpoon Therapeutics (HARP) United States $0.613B 0.00
Flexion Therapeutics (FLXN) United States $0.590B 0.00
Molecular Templates (MTEM) United States $0.589B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.581B 0.00
Siga Technologies (SIGA) United States $0.557B 15.63
Crinetics Pharmaceuticals (CRNX) United States $0.497B 0.00
Sundial Growers (SNDL) Canada $0.488B 0.00
PROFOUND MEDICL (PROF) Canada $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
Altimmune (ALT) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.431B 0.00
CASI Pharmaceuticals (CASI) United States $0.429B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
Rafael Holdings (RFL) United States $0.396B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.394B 0.00
Jounce Therapeutics (JNCE) United States $0.384B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 9.68
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.347B 0.00
Concert Pharmaceuticals (CNCE) United States $0.334B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.329B 0.00
Alpine Immune Sciences (ALPN) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.306B 19.73
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Menlo Therapeutics (VYNE) United States $0.299B 0.00
Redhill Biopharma (RDHL) Israel $0.291B 0.00
Xeris Pharmaceuticals (XERS) United States $0.275B 0.00
Jaguar Animal Health (JAGX) United States $0.263B 0.00
Otonomy (OTIC) United States $0.250B 0.00
IMV INC (IMV) Canada $0.248B 0.00
CTI BioPharma (CTIC) United States $0.239B 0.00
Oncternal Therapeutics (ONCT) United States $0.226B 0.00
Infinity Pharmaceuticals (INFI) United States $0.223B 0.00
Calithera Biosciences (CALA) United States $0.219B 0.00
OptiNose (OPTN) United States $0.215B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.213B 0.00
IsoRay (ISR) United States $0.210B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Novan (NOVN) United States $0.185B 0.00
Aquestive Therapeutics (AQST) United States $0.183B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.172B 0.00
Onconova Therapeutics (ONTX) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
ProPhase Labs (PRPH) United States $0.145B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Lipocine (LPCN) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.108B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.105B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Natural Alternatives (NAII) United States $0.083B 161.13
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.072B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Recro Pharma (REPH) United States $0.072B 0.00
AgeX Therapeutics (AGE) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.069B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Iterum Therapeutics (ITRM) Ireland $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.058B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.58
Regulus Therapeutics (RGLS) United States $0.045B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.74
Neos Therapeutics (NEOS) United States $0.037B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
Flex Pharma (SLRX) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 31.90
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00